Last updated: 2026-09-07 19:24:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Mind Medicine (MindMed) Inc. (MNMD) operates in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalisation of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- |
Mind Medicine (MindMed) Inc. (MNMD) last closed at $-- as of --, -- from the previous close of $--.
During the latest regular trading session, MNMD traded between $-- and $--, with a volume of -- shares. The closing price was -- and --.
Over the past seven days, Mind Medicine (MindMed) Inc. (MNMD) moved from $13,70 to $15,02, representing a gain of 9,64% ($1,32).
The stock traded between $12,88 and $15,29 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 2,47 million shares, up versus the previous seven-day period, indicating higher trading activity.
Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).
| Industry | MEDICINAL CHEMICALS & BOTANICAL PRODUCTS |
| Employees | 74 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Mind Medicine (MindMed) Inc. (MNMD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.